Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Please note: Medicare does not allow drug coverage for Part D-excluded use, such as weight loss
:max_bytes(150000):strip_icc()/VWH-GettyImages-2275860768-a6f6e63304e048d0a829844c1dacbd8d.jpg)
Patrick, R
In this randomized trial of more than 9300 subjects with T2DM and high cardiovascular risk, liraglutide was seen to decrease the incidence of the composite cardiovascular primary endpoint (occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke) compared with placebo (13.0 and 14.9% in the liraglutide and placebo group, respectively
This synergistic interaction provides both metabolic and immunological benefits and creates a more comprehensive effect than either component alone (Swanson et al., 2020
US$ 21.29
US$ 25.86
![Classification of GLP-1 RAs based on different parameters [13]](https://www.researchgate.net/publication/343265981/figure/tbl1/AS:923164464906240@1597110968484/Classification-of-GLP-1-RAs-based-on-different-parameters-13.png)
US$ 21.77
US$ 27.20
